Bortenat 3.5mg contains Bortezomib, a chemotherapy drug used to treat certain types of blood cancer. It works by blocking specific proteins in cancer cells, leading to their death. ✅ Primary Uses: Multiple Myeloma A type of blood cancer that affects plasma cells in the bone marrow. Bortenat helps slow disease progression and reduce symptoms. Mantle Cell Lymphoma (MCL) A rare, aggressive form of non-Hodgkin lymphoma. Bortenat is used when other treatments haven't worked or as a first-line treatment in some cases. ⚙️ How It Works: Bortezomib inhibits proteasomes, which are cell structures that break down proteins. Blocking this process causes a buildup of proteins in cancer cells, leading to cell stress and death—especially in fast-growing cancer cells. 💉 Administration: Given by injection under the skin (subcutaneously) or directly into a vein (intravenously). Administered in cycles under the guidance of a healthcare professional, often in a hospital or oncology clinic. ⚠️ Common Side Effects: Fatigue or weakness Nausea, vomiting, or diarrhea Low blood cell counts (risk of infection, anemia) Nerve pain or tingling (peripheral neuropathy) Dizziness or low blood pressure ❗ Precautions: Monitor blood counts and liver function regularly during treatment. Not recommended during pregnancy or breastfeeding. Inform your doctor about other medications or existing health conditions before starting.
Send Message